Les Business Angels des Grandes Écoles

Les Business Angels des Grandes Écoles is a prominent angel network established in 2004 and based in Paris, France. This organization connects experienced investors, known as business angels, with innovative entrepreneurs seeking funding and mentorship. As one of the leading networks in France, it plays a crucial role in fostering the growth of startups by providing not only financial support but also valuable expertise and industry connections. Through its extensive network, Les Business Angels des Grandes Écoles aims to facilitate the development of new business ventures, contributing to the entrepreneurial ecosystem in the country.

12 past transactions

Kinvent

Venture Round in 2021
KINVENT is actively involved in the fields of physical rehabilitation and sports biomechanics producing innovative measuring and training devices for the facilitation of every day and athletic movements. Our strengths at KINVENT is that we can think and produce solutions to any challenge of sports biomechanics and physical rehabilitation. Triangular force plates for visual feedback balance training, sensors for continuous 3D kinematic analysis in the water, force sensors for kite surf, accelerometers for rowing and sailing, are some of our on demand products. If you are looking for excellence in hardware and software solutions for your work... work with us. Our KFORCE solution is a range of torque measuring instruments for human strength, balance and motion. This system consists of six instruments with high-precision measuring equipment, which concentrate all the know-how of K-INVENT. The display of the data recorded by the device sensors is transcribed by the KFORCE software, installed on any iOS or Android terminal. This accessory capable of reading and re-transcribing the information given by all dynamometers of the entire range is usable on smartphones or tablets with Android and IOS operating system

PEP-Therapy

Series A in 2021
PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

PEP-Therapy

Series A in 2021
PEP-Therapy is a biotechnology company developing first-in-class peptides as targeted therapies for severe diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for the intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

Imageens

Seed Round in 2021
Imageens develops a Web AI-Based platform for medical images analysis that empower professionals Imaging productivity by providing faster processing as well as more accurate and reliable reporting.

OncoDiag

Series A in 2021
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.

Wefight

Seed Round in 2019
Wefight is an open door for patients treated outside clinical settings. It makes it possible to offer services and facilitates the collect of data in real life. Our goal: to secure patients at home and save time for care teams.

Trainme

Seed Round in 2019
trainme, SAS owns and operates a community platform of sports courses connecting individuals with sports professionals. The company was incorporated in 2015 and is based in Paris, France.

Cardiawave

Venture Round in 2018
Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging. Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.

Cypheme

Angel Round in 2017
Cypheme is an artificial intelligence capable of detecting counterfeit products by analyzing the product's packaging with a neural network, using only a cellphone camera.

Cardiawave

Venture Round in 2017
Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging. Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.

Telegrafik

Venture Round in 2017
Telegrafik is an intelligent analysis platform for data from sensors for home care. Telegrafik proposes Internet-of-Things solutions for the SMART CARE market. It developed a smart care software platform that transforms home sensors’ data into added-value services, such as smart alerting and smart monitoring.

CineGV

Seed Round in 2014
With CinéGV terminals, download in 30 seconds on a USB / micro USB or SD card, movies or series you dream to see. For all your travels, by train, by car, at the hotel ... and even at home! Wherever you are, enjoy a real movie on your computer, tablet or smartphone. Find the box office and TV hits in a prestigious catalog, regularly updated.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.